The overall objective of this proposal is to establish a New York Regional Thalassemia Center (NYRTC) that could participate in the development and establishment of the NIH Thalassemia Clinical Research Network (TCRN). Key research in thalassemia and the meaningful evaluation of new therapies would be greatly enhanced by the creation of this network. In preliminary work, the investigators have developed a group of 12 regional institutions caring for more than 200 patients and have begun compiling a patient database. Members of the NYRTC have identified two central subjects for investigation as models for collaborative trials: hepatitis C( HCV) infection and osteoporosis. The first study proposes combination therapy to treat HCV, a complication common among patients transfused before blood screening which leads to increased risk of liver disease (fibrosis, cirrhosis, cancer) from both iron overload and HCV. Interferon alone is effective in only 10% of cases. Pilot studies combining interferon and ribavirin show promise. The investigators propose to include analysis of iron status patient and host specific disease modifiers, including mutations of the HFE gene. These mutations affect gastrointestinal iron absorption and the investigators have found are associated with low CD8 immunotype. The second study centers on evaluation and treatment of osteoporosis. Iron overload influences bone metabolism both directly and indirectly through effects on the immune, endocrine and hematopoietic systems. Markers of bone formation and resorption will be correlated with bone mineral density and a variety of iron-related parameters as well as the above mentioned host specific disease modifiers. A clinical trial will be undertaken to assess the effectiveness of pamidronate, a drug that inhibits bone resorption. Again, the impact of iron and the disease modifiers will be examined. These studies are ideally suited to multicenter collaborations.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL065244-02
Application #
6390816
Study Section
Special Emphasis Panel (ZHL1-CSR-C (M1))
Program Officer
Peterson, Charles M
Project Start
2000-07-01
Project End
2005-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
2
Fiscal Year
2001
Total Cost
$339,900
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Morris, Claudia R; Kim, Hae-Young; Klings, Elizabeth S et al. (2015) Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia. Br J Haematol 169:887-98
Tubman, Venée N; Fung, Ellen B; Vogiatzi, Maria et al. (2015) Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort. J Pediatr Hematol Oncol 37:e162-9
Trachtenberg, Felicia L; Gerstenberger, Eric; Xu, Yan et al. (2014) Relationship among chelator adherence, change in chelators, and quality of life in thalassemia. Qual Life Res 23:2277-88
Green, Sage T; Martin, Marie B; Haines, Dru et al. (2014) Variance of pain prevalence and associated severity during the transfusion cycle of adult thalassaemia patients. Br J Haematol 166:797-800
Grady, Robert W; Galanello, Renzo; Randolph, Rachel E et al. (2013) Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine. Haematologica 98:129-35
Porter, John B; Wood, John; Olivieri, Nancy et al. (2013) Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone. J Cardiovasc Magn Reson 15:38
Oliveros, Olivia; Trachtenberg, Felicia; Haines, Dru et al. (2013) Pain over time and its effects on life in thalassemia. Am J Hematol 88:939-43
Haines, Dru; Martin, Marie; Carson, Susan et al. (2013) Pain in thalassaemia: the effects of age on pain frequency and severity. Br J Haematol 160:680-7
Morris, Claudia R; Kim, Hae-Young; Wood, John et al. (2013) Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica 98:1359-67
Walter, Patrick B; Porter, John; Evans, Patricia et al. (2013) Increased leucocyte apoptosis in transfused ?-thalassaemia patients. Br J Haematol 160:399-403

Showing the most recent 10 out of 25 publications